3,4-dihydroxyphenylacetic acid has been researched along with 22q11.2 Deletion Syndrome in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Didriksen, M | 1 |
| Fejgin, K | 1 |
| Nilsson, SR | 1 |
| Birknow, MR | 1 |
| Grayton, HM | 1 |
| Larsen, PH | 1 |
| Lauridsen, JB | 1 |
| Nielsen, V | 1 |
| Celada, P | 1 |
| Santana, N | 1 |
| Kallunki, P | 1 |
| Christensen, KV | 1 |
| Werge, TM | 1 |
| Stensbøl, TB | 1 |
| Egebjerg, J | 1 |
| Gastambide, F | 1 |
| Artigas, F | 1 |
| Bastlund, JF | 1 |
| Nielsen, J | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and 22q11.2 Deletion Syndrome
| Article | Year |
|---|---|
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Auditory Perception; Corpus Striatum; DiGeorge Syndr | 2017 |